samedan logo
 
 
spacer
home > pmps > summer 2021 > getting maintenance just right
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Getting Maintenance Just Right

With the ongoing success of the coronavirus vaccine rollout, hopes of a swift recovery from the economic downturn caused by COVID-19 are once again beginning to grow.

It’s clear that, despite the silver lining offered by the vaccine programme, the UK’s pharma manufacturing industry faces a drawn-out fight to survive the current crisis before it can move on to a more prosperous future.

Supply chains have been impacted, workforces have been laid low, and factory floors have had to adapt quickly to reams of new health and safety requirements.

In this challenging environment, where short-term survival tactics have to be balanced against medium- and long-term recovery strategies, it can be difficult to prioritise where to cut costs and where to invest.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Crow is Managing Director of digital transformation specialist, Nexer. Colin has 30 years of experience in designing, procuring, implementing and providing support for complex IT systems, with a specific focus on enterprise resource planning solutions including Oracle, SAP and Microsoft NAV, CRM, and AX – now Business Central and Dynamics 365. He has operated in many sectors throughout his career, including manufacturing, retail, distribution, pharmaceutical, healthcare, public sector, food and beverage, telecoms, and financial services. Colin has built a reputation for delivering long-term business benefits, productivity improvement, and cost reduction. Since 2019, Colin has been Managing Director of digital transformation consultancy Nexer where he and his team work with manufacturing, field service, and wholesale distribution companies such as Regatta, Staples Vegetables, Lifestyle Sports, and SE Controls to challenge the status quo with the help of cutting-edge technology.
spacer
Colin Crow
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

First own Gerresheimer Autoinjector - Gerresheimer and Midas Pharma announce strategic partnership

– Gerresheimer’s first own IP autoinjector suitable for both small and large molecules enhances broad portfolio of solutions, medical devices and pharmaceutical primary packaging – First joint project of Gerresheimer and Midas Pharma: Development and marketing of new autoinjector – One-stop-shop for biotech and pharma customers Duesseldorf, November 08, 2021 – Gerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a strategic partnership. The joint project comprises the development and marketing of the new generation autoinjector.
More info >>

White Papers

What is process characterization?

EXPUTEC

Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement